VS
Compare Harvest Healthcare Leaders Income ETF (HHL) vs BMO Covered Call Health Care ETF (ZWHC) to find the best fit for your portfolio. HHL provides Healthcare and Sovereign exposures, while ZWHC is primarily weighted in Healthcare. When evaluating costs, HHL features a management fee (MER) of 0.85%, compared to 0.73% for ZWHC. Performance-wise, HHL has returned 0.32% year-to-date with +$354 M in net flows, whereas ZWHC is at 1.92% with +$15 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
HHL
ZWHC
| AuM | $1,833.20 M | $42.54 M |
| Management Fees | 0.85% | 0.73% |
| Exp. ratio | 0.98% | 0.73% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 9, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | HHL | -3.52% | +4.74% | -0.32% | +8.86% | +18.71% |
ZWHC | -2.39% | +5.30% | +1.92% | +9.70% | +17.52% | |
| Flows | HHL | -$1 M | +$41 M | +$354 M | +$356 M | +$688 M |
ZWHC | -$1 M | +$5 M | +$15 M | +$19 M | +$33 M |
HHL vs ZWHC exposure
Countries
HHL
USA
84.21%
Other
15.79%
ZWHC
USA
95.73%
Sectors
HHL
Healthcare
98.89%
ZWHC
Healthcare
100.46%
As of September 9, 2026
Top 10 Holdings
HHL
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%
ZWHC
UnitedHealth Group, Inc.
6.31%
Eli Lilly & Co.
5.72%
Thermo Fisher Scientific, Inc.
5.72%
Elevance Health, Inc.
5.60%
Amgen, Inc.
5.33%
Vertex Pharmaceuticals, Inc.
5.31%
Merck & Co., Inc.
5.30%
Cardinal Health, Inc.
5.21%
The Cigna Group
5.18%
Johnson & Johnson
5.17%
Diversification
HHL
Total weight of top 10 holdings out of 25 total
50.34%
ZWHC
Total weight of top 10 holdings out of 20 total
54.86%
Characteristics
Compare
HHL
ZWHC
| Provider | Harvest Portfolios Group | BMO |
| Management | Actively managed | Actively managed |
| Benchmark | - | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 10.03% | 7.00% |
| Meets ESG criteria | No | No |
| Inception Date | December 18, 2014 | January 23, 2023 |
Frequently asked questions about HHL and ZWHC
Which ETF has performed better year to date: HHL or ZWHC?
As of September 9, 2026, HHL has returned -0.32% year to date, while ZWHC has returned 1.92%. ZWHC is ahead on YTD performance.
Which ETF is larger by assets under management: HHL or ZWHC?
As of September 9, 2026, HHL manages $1.83 B in assets, while ZWHC manages $42.54 M. HHL is the larger fund by AUM.
How are HHL and ZWHC managed?
HHL is actively managed by Harvest Portfolios Group. It does not track an index. ZWHC is actively managed by BMO. It does not track an index.
What sectors do HHL and ZWHC emphasize?
HHL is most exposed to Healthcare and Sovereign. ZWHC is most exposed to Healthcare.
Which ETF is attracting more investor flows: HHL or ZWHC?
Year to date, HHL has seen +$354.17 M in net flows, compared with +$14.67 M for ZWHC. HHL has attracted more net investor money so far.
How do the fees of HHL and ZWHC compare?
HHL has an expense ratio of 0.98%, while ZWHC has an expense ratio of 0.73%.
What are the top holdings of HHL and ZWHC?
HHL's largest holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp., and Bristol Myers Squibb Co.. ZWHC's top holdings include UnitedHealth Group, Inc., Eli Lilly & Co., and Thermo Fisher Scientific, Inc..
Which ETF is more diversified: HHL or ZWHC?
HHL holds 25 securities, while ZWHC holds 20. On holdings count, HHL is the more diversified portfolio.
Recent articles about HHL and ZWHC
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.